(2-(Allyloxy)-3-chloropyridin-4-yl)boronic acid

Catalog No. :
ACQJGE190
CAS No. :
1987879-17-3
Molecular Formula :
C8H9BClNO3
Molecular Weight :
213.43

IUPAC Name:(2-(allyloxy)-3-chloropyridin-4-yl)boronic acid

(2-(Allyloxy)-3-chloropyridin-4-yl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$68.00Login to see priceInquiryInquiry
1g95%$162.00Login to see priceInquiryInquiry
5g95%$485.00Login to see priceInquiryInquiry
10g95%$646.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2-(Allyloxy)-3-chloropyridin-4-yl)boronic acid
IUPAC Name(2-(allyloxy)-3-chloropyridin-4-yl)boronic acid
MDL No.MFCD21609522
Molecular FormulaC8H9BClNO3
Molecular Weight213.43
SMILESOB(C1=C(Cl)C(OCC=C)=NC=C1)O
InChI KeyCNPGUURWDPSOMO-UHFFFAOYSA-N
Synonym2-Allyloxy-3-chloropyridine-4-boronic acid;(2-(Allyloxy)-3-chloropyridin-4-yl)boronic acid;Boronic acid, B-[3-chloro-2-(2-propen-1-yloxy)-4-pyridinyl]-
CAS No.1987879-17-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACQJGE190 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUNGY257 route compound structure diagram
    ACUNGY257951677-39-7 In Stock
  4. Then
  5. ACQJGE190 route product structure diagram
    ACQJGE1901987879-17-3
Inquiry

2. ACQJGE190 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQJGE190 route product structure diagram
    ACQJGE1901987879-17-3
Inquiry

Comments (0)